This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Prescribing Information and Adverse Event Reporting can be found at the bottom of this webpage.

Accessing Biologics for CRSwNP patients with co-morbid Severe Asthma

This is a promotional webinar organised and funded by GSK, including a paid speaker, for UK Healthcare Professionals. An expert-led webinar delving in to how biologics work in CRSwNP, the effect of biologics across both the upper and lower airway and how collaboration between ENT and Respiratory HCP's to identify CRSwNP patients with co-morbid Severe Asthma could improve access for these patients to a biologic. This is showcased with a case-study from Musgrove Park Hospital.

Register for the following sessions

24 Feb, 2025

Mr Edward Chisholm MD, FRCS (ORL-HNS), Consultant ENT Surgeon,

Dr Dinesh Shrikrishna BSc (Hons), FRCP, PhD, Consultant Respiratory Physician,

12 Mar, 2025

Mr Edward Chisholm MD, FRCS (ORL-HNS), Consultant ENT Surgeon,

Dr Dinesh Shrikrishna BSc (Hons), FRCP, PhD, Consultant Respiratory Physician,

CRSwNP, Chronic rhinosinusitis with nasal polyps.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.